Improvement of myocardial glycolipid metabolic disorder in diabetic hamster with Astragalus polysaccharides treatment

Molecular Biology Reports

Volumn 39, Issue 7, 2012, Pages 7609-7615

  Chen, Wei ^a   Xia, Yan Ping ^a   Chen, Wen Jie ^a   Yu, Mao Hua ^a   Li, Yi Ming ^a   Ye, Hong Ying ^a  

^a FUDAN UNIVERSITY   (China)

Author keywords

Astragalus polysaccharides; Cardiomyopathy; Diabetes; Glycolipid metabolism

Indexed keywords

ACETYL COENZYME A SYNTHETASE; ASTRAGALUS POLYSACCHARIDE; C PEPTIDE; ENZYME; FATTY ACID TRANSPORTER; GLUCOSE TRANSPORTER 4; GLYCOGEN; GLYCOLIPID; GLYCOSYLATED PROTEIN; HERBACEOUS AGENT; INSULIN; MESSENGER RNA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR ALPHA; POLYSACCHARIDE; SODIUM CHLORIDE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DIABETIC CARDIOMYOPATHY; DRUG EFFECT; DRUG MECHANISM; GENE EXPRESSION; GLUCOSE BLOOD LEVEL; GLUCOSE METABOLISM; HAMSTER; HEART MUSCLE METABOLISM; HEART PROTECTION; LIPID BLOOD LEVEL; LIPID METABOLISM; MALE; METABOLIC DISORDER; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STREPTOZOCIN DIABETES; ULTRASTRUCTURE;

ANIMALS; ASTRAGALUS PLANT; BLOOD GLUCOSE; C-PEPTIDE; CRICETINAE; DIABETES MELLITUS, EXPERIMENTAL; GLUCOSE TRANSPORTER TYPE 4; INSULIN; LIPID METABOLISM; LIPIDS; MALE; MYOCARDIUM; PHYTOTHERAPY; PLANT EXTRACTS; POLYSACCHARIDES; PPAR GAMMA;

CRICETINAE;

EID: 84864185481     PISSN: 03014851     EISSN: 15734978     Source Type: Journal    
DOI: 10.1007/s11033-012-1595-y     Document Type: Article

References (11)

1. Chen W, YU M-H, LI Y-M et al (2008) Astragalus polysaccha-rides: an effective treatment for diabetes prevention in NOD mice. Exp Clin Endocrinol Diabetes 116(8):468-474
2. CHEN W, YU M-H, LI Y-M et al (2007) Effects of Astragalus polysaccharides on chymase, angiotensin-converting enzyme and angiotensin II in diabetic cardiomyopathy in hamsters. J Int Med Res 35(6):873-877 (Pubitemid 350238419)
3. CHEN W, YU M-H, LI Y-M et al (2010) Astragalus polysac-charides inhibited diabetic cardiomyopathy in hamsters depending on suppression of heart chymase activation. J Diabetes Complications 24(3):199-208
4. Chen W, YU M-H, LI Y-M et al (2009) Beneficial effects of astragalus polysaccharides treatment on cardiac chymase activities and cardiomyopathy in diabetic hamsters. Acta Diabetol 47(suppl 1):535-546
5. Mohammad A, Sharma V, Mcneill JH (2002) Vanadium increases GLUT4 in diabetic rat skeletal muscle. Mol Cell Biochem 233(1):139-143 (Pubitemid 34746120)
6. Watson RT, Pessin J (2001) Intracellular organization of insulin signaling and GLUT4 translocation. Recent Prog Horm Res 56:175-193
7. Suden MC, Bulmer K, Gibbons GF et al (2002) Peroxisome-proliferator activated receptor alpha deficiency leads to dysreg-ulation of hepatic lipid and carbohydrate metabolism by fatty acids and insulin. Biochem J 364:361-368 (Pubitemid 34620795)
8. Lee SS, Chan WY, Lo CK et al (2004) Requirement of PPAR-alpha in maintaining phospholipid and triacylglycerol homeo-stasis during energy deprivation. J Lipid Res 45:2025-2037 (Pubitemid 40990897)
9. Farrell GC, Robertson G, Auwerx J et al (2003) Central role of PPAR-alpha-dependent hepatic lipid turnover in dietary steato-hepatitis in mice. Hepatology 38:123-132 (Pubitemid 36775803)
10. Laukkanen Johanna, Yla-Herruala Seppo (2002) Genes involved in Atherosclerosis. Exp Nephrol 10:150-163
11. Sundvold H, Lien S (2001) Identification of a novel peroxisome proliferator-activated receptor (PPAR) promoter in man and transactivation by the nuclear receptor ROR alpha1. Biochem Biophys Res Commun 287(2):383-390 (Pubitemid 32917609)